BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12150517)

  • 1. Differential effects of short-chain fatty acids on head and neck squamous carcinoma cells.
    Krishna S; Brown N; Faller DV; Spanjaard RA
    Laryngoscope; 2002 Apr; 112(4):645-50. PubMed ID: 12150517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
    Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
    Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7beta-hydroxycholesterol induces apoptosis and regulates cyclooxygenase 2 in head and neck squamous cell carcinoma.
    Heiduschka G; Erovic BM; Vormittag L; Skoda C; Martinek H; Brunner M; Ehrenberger K; Thurnher D
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):261-7. PubMed ID: 19289704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation.
    Ohata A; Usami M; Miyoshi M
    Nutrition; 2005; 21(7-8):838-47. PubMed ID: 15975492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas.
    Erlich RB; Rickwood D; Coman WB; Saunders NA; Guminski A
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):381-9. PubMed ID: 18398612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon.
    Waldecker M; Kautenburger T; Daumann H; Busch C; Schrenk D
    J Nutr Biochem; 2008 Sep; 19(9):587-93. PubMed ID: 18061431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.
    Wu Y; Palad AJ; Wasilenko WJ; Blackmore PF; Pincus WA; Schechter GL; Spoonster JR; Kohn EC; Somers KD
    Clin Cancer Res; 1997 Nov; 3(11):1915-21. PubMed ID: 9815580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells.
    Rossi MJ; Sundararaj K; Koybasi S; Phillips MS; Szulc ZM; Bielawska A; Day TA; Obeid LM; Hannun YA; Ogretmen B
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):55-62. PubMed ID: 15632910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma.
    Hoa M; Davis SL; Ames SJ; Spanjaard RA
    Cancer Res; 2002 Dec; 62(24):7154-6. PubMed ID: 12499248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked inhibition of growth and invasive parameters of head and neck squamous carcinoma FaDu by a nutrient mixture.
    Roomi MW; Roomi NW; Kalinovsky T; Rath M; Niedzwiecki A
    Integr Cancer Ther; 2009 Jun; 8(2):168-76. PubMed ID: 19679626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
    Scher RL
    Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38.
    Thomas SM; Zeng Q; Epperly MW; Gooding WE; Pastan I; Wang QC; Greenberger J; Grandis JR
    Clin Cancer Res; 2004 Oct; 10(20):7079-87. PubMed ID: 15501988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation.
    Blottière HM; Buecher B; Galmiche JP; Cherbut C
    Proc Nutr Soc; 2003 Feb; 62(1):101-6. PubMed ID: 12740064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
    Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
    Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
    Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H; Sen S; Mathur M; Bahadur S; Singh N
    Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human-in-mouse modeling of primary head and neck squamous cell carcinoma.
    Law JH; Whigham AS; Wirth PS; Liu D; Pham MQ; Vadivelu S; Kirkbride KC; Brown BT; Burkey BB; Sinard RJ; Netterville JL; Yarbrough WG
    Laryngoscope; 2009 Dec; 119(12):2315-23. PubMed ID: 19693929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.